Bismuth subcitrate potassium / Metronidazole / Tetracycline hydrochloride - paediatric investigation plan
bismuth subcitrate potassium
Metronidazole
tetracycline hydrochloride
PIPHuman
Latvian is available via eTranslation, the European Commission's machine translation service.
Translate to Latvian | Important information about machine translation
Key facts
- Active substance
- bismuth subcitrate potassium
- Metronidazole
- tetracycline hydrochloride
- Therapeutic area
- Gastroentology-Hepatology
- Decision number
- P/74/2009
- PIP number
- Bismuth subcitrate potassium / Metronidazole / Tetracycline hydrochloride
- Pharmaceutical form(s)
- Capsule
- Condition(s) / indication(s)
- Helicobacter pylori infection
- Route(s) of administration
- Oral use
- Contact for public enquiries
Axcan Pharma SA
E-mail: cboudes@axcan.com
Country: France
Phone: +33 130461916
Fax: +33 130466547- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date
- Compliance check done
- Nē